{"id":"W2737770503","doi":"10.1177/1078155217718381","title":"Utilization of capecitabine plus oxaliplatin and 5-fluorouracil/folinic acid plus oxaliplatin in the adjuvant treatment of stage IIB and stage III colon cancer: A multi-centre, retrospective, chart review study","year":2017,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"BC Cancer Agency","keywords":"Oxaliplatin; Medicine; Folinic acid; FOLFOX; Capecitabine; Colorectal cancer; Fluorouracil; Tolerability; Regimen; Internal medicine; Stage (stratigraphy); Surgery; Cancer; Oncology; Gastroenterology; Adverse effect","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001523472,0.0002637094,0.001487949,0.0001234612,0.0002239936,0.00002163246,0.000147068,0.00005902195,0.0001122288],"category_scores_gemma":[0.001124139,0.0001658505,0.000109703,0.0001454515,0.0002104424,0.0004644124,0.00008864372,0.0003409924,4.486097e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008775871,"about_ca_system_score_gemma":0.000672675,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001739521,"about_ca_topic_score_gemma":0.002064154,"domain_scores_codex":[0.9974322,0.0005575199,0.001086878,0.0002696601,0.0004287516,0.0002250208],"domain_scores_gemma":[0.9952687,0.0006409027,0.003100587,0.0002908536,0.0005889835,0.0001099953],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03849655,0.01454166,0.7141815,0.001472574,0.004082371,0.002567395,0.04660568,0.0000286863,0.00326628,0.00005738655,0.000828838,0.173871],"study_design_scores_gemma":[0.1523333,0.0290596,0.7114316,0.001773909,0.008639041,0.0008454365,0.0272655,0.001207396,0.002015121,0.000006741185,0.06503869,0.0003836043],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9205781,0.06922752,0.000008488972,0.007140083,0.0002444308,0.002077911,0.00007313291,0.000004482618,0.0006458873],"genre_scores_gemma":[0.8244708,0.1744972,0.0002961156,0.000251052,0.0001030764,0.00005329433,0.000003586009,0.00001344243,0.0003113902],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1734874,"threshold_uncertainty_score":0.6763188,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1493973258693315,"score_gpt":0.4807132871241634,"score_spread":0.3313159612548319,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}